GGI
TAK icon

Godsey & Gibb Inc’s Takeda Pharmaceutical TAK Stock Holding History

Godsey & Gibb Inc’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$783 Buy
+43
New +$761 ﹤0.01% 438

Other funds holding TAK

LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MLFP
MPS Loria Financial Planners Burr Ridge, Illinois $527M AUM 17.98% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
AP
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return

Godsey & Gibb Inc's TAK Position: Q3 2026 in Review

Godsey & Gibb Inc opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 43 shares worth $783. The stake represents ﹤0.01% of the portfolio and ranks #438 among its holdings.

32 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Godsey & Gibb Inc held 43 shares of Takeda Pharmaceutical worth $783 as of Q3 2026.
  • Takeda Pharmaceutical was a new Godsey & Gibb Inc position in Q3 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q3 2026, its #438 holding.
  • 32 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Godsey & Gibb Inc's 13F filing for Q3 2026, filed 14 Oct 2026.